Home > Financial Ratios > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -59.12655.88-122.1254.92-1.40

What is the latest Core EBITDA Growth ratio of AKUMS DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of AKUMS DRUGS & PHARMACEUTICALS is -59.12 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-59.12
Mar2023655.88
Mar2022-122.12
Mar202154.92
Mar2020-1.40

How is Core EBITDA Growth of AKUMS DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 -59.12
Negative
Mar2023 655.88
Positive
Mar2022 -122.12
Negative
Mar2021 54.92
Positive
Mar2020 -1.4 -

Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of AKUMS DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS ₹7,490.7 Cr 3.5% 6.1% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,706.0 Cr 2.3% 11.7% 5.1% Stock Analytics
DIVIS LABORATORIES ₹152,946.0 Cr -1.6% 4% 58.7% Stock Analytics
CIPLA ₹120,751.0 Cr 0.8% 6.2% -2.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,988.0 Cr 0.7% 9.8% 19.8% Stock Analytics
DR REDDYS LABORATORIES ₹96,066.7 Cr -1% 2.8% -8% Stock Analytics


AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS

3.5%

6.1%

NA
SENSEX

-1.3%

4.2%

3.6%


You may also like the below Video Courses